Shanghai (1)

Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma (1)

Recruiting (1)

phase 2 (1)

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)

toripalimab+cetuximab (1)

drug (1)

Other (1)

Interventional (1)

patients with locally recurrent resectable head and neck squamous cell carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

Shanghai, Shanghai, China

the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni

Nov 1, 2022